INTERNATIONAL PATENT: HEIDELBERG PHARMA RESEARCH GMBH FILES APPLICATION FOR "MODULAR LINKER COMPOUND FOR TARGET-BINDING DRUG CONJUGATES"

GENEVA, June 16 -- HEIDELBERG PHARMA RESEARCH GMBH (Gregor-Mendel-Str. 2268526 Ladenburg) filed a patent application (PCT/EP2024/084925) for "MODULAR LINKER COMPOUND FOR TARGET-BINDING DRUG CONJUGATES" on Dec 05, 2024. With publication no. WO/2025/120085, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MULLER, Christoph (c/o Heidelberg Pharma Research GmbH, Gregor-Mendel-Str. 2268526 Ladenburg), GRUSS, Hendrik (c/o Heidelberg Pharma Research GmbH, Gregor-Mendel-Str. 2268526 Ladenburg), HECHLER, Torsten (c/o Heidelberg Pha...